Literature DB >> 7448479

Positive and negative schizophrenic symptoms and the role of dopamine.

T J Crow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7448479

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN： 0007-1250            Impact factor:   9.319


× No keyword cloud information.
  36 in total

Review 1.  Measuring neuropsychological change in schizophrenia with novel antipsychotic medications.

Authors:  S E Purdon
Journal:  J Psychiatry Neurosci       Date:  2000-03       Impact factor: 6.186

Review 2.  Functional brain mapping of psychopathology.

Authors:  G D Honey; P C Fletcher; E T Bullmore
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-04       Impact factor: 10.154

Review 3.  Negative symptoms: psychopathological models.

Authors:  J Ananth; A Djenderdjian; P Shamasunder; J Costa; J Herrera; J Sramek
Journal:  J Psychiatry Neurosci       Date:  1991-03       Impact factor: 6.186

Review 4.  Positive-negative symptom assessment in schizophrenia: psychometric issues and scale comparison.

Authors:  S R Kay
Journal:  Psychiatr Q       Date:  1990

Review 5.  Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research.

Authors:  Julie W Messinger; Fabien Trémeau; Daniel Antonius; Erika Mendelsohn; Vasthie Prudent; Arielle D Stanford; Dolores Malaspina
Journal:  Clin Psychol Rev       Date:  2010-09-18

6.  PAOPA, a potent analogue of Pro-Leu-glycinamide and allosteric modulator of the dopamine D2 receptor, prevents NMDA receptor antagonist (MK-801)-induced deficits in social interaction in the rat: implications for the treatment of negative symptoms in schizophrenia.

Authors:  Bailee Dyck; Kelly Guest; Christal Sookram; Dipannita Basu; Rodney Johnson; Ram K Mishra
Journal:  Schizophr Res       Date:  2010-10-30       Impact factor: 4.939

Review 7.  Progress in defining optimal treatment outcome in schizophrenia.

Authors:  Gary Remington; George Foussias; Ofer Agid
Journal:  CNS Drugs       Date:  2010-01       Impact factor: 5.749

8.  Heterogeneity of structural brain changes in subtypes of schizophrenia revealed using magnetic resonance imaging pattern analysis.

Authors:  Tianhao Zhang; Nikolaos Koutsouleris; Eva Meisenzahl; Christos Davatzikos
Journal:  Schizophr Bull       Date:  2014-09-26       Impact factor: 9.306

9.  Assessing Reality Testing in Mice Through Dopamine-Dependent Associatively Evoked Processing of Absent Gustatory Stimuli.

Authors:  Benjamin R Fry; Nicollette Russell; Ryan Gifford; Cindee F Robles; Claire E Manning; Akira Sawa; Minae Niwa; Alexander W Johnson
Journal:  Schizophr Bull       Date:  2020-01-04       Impact factor: 9.306

10.  Behavioral perturbations after prenatal neurogenesis disturbance in female rat.

Authors:  Franck Hazane; Marie-Odile Krebs; Thérèse M Jay; Gwenaëlle Le Pen
Journal:  Neurotox Res       Date:  2009-03-06       Impact factor: 3.911
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.